tiprankstipranks
Achilles to end development of TIL-based cNeT therapy, conduct strategic review
PremiumThe FlyAchilles to end development of TIL-based cNeT therapy, conduct strategic review
2M ago
Achilles Therapeutics Excels in Q2 with Promising Trials
Premium
Company Announcements
Achilles Therapeutics Excels in Q2 with Promising Trials
3M ago
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
Premium
The Fly
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
3M ago
Achilles Therapeutics Addresses Nasdaq Notice
PremiumCompany AnnouncementsAchilles Therapeutics Addresses Nasdaq Notice
6M ago
Achilles Therapeutics: Promising Q1 2024 Results
Premium
Company Announcements
Achilles Therapeutics: Promising Q1 2024 Results
7M ago
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
Premium
The Fly
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
7M ago
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
PremiumThe FlyAchilles Therapeutics provides update on Phase I/IIa NSCLC results
8M ago
Achilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Achilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
9M ago
Achilles announces publication on neoantigen immunogenicity prediction
Premium
The Fly
Achilles announces publication on neoantigen immunogenicity prediction
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100